Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary reveals strong financial performance, with positive growth in key areas such as revenue and operating income. The Q&A section highlights robust client retention, effective inflation management, and strategic investments in AI, enhancing productivity. Despite some unclear responses, the overall sentiment is positive, supported by strategic growth in Europe and new contracts. The company's optimistic guidance and focus on technology investments further bolster the positive outlook.
Organic Revenue $4.8 billion in Q1 FY2026, a 5% increase year-over-year. Growth would have been approximately 8% without the calendar shift. Growth driven by strong base business and net new business.
FSS U.S. Organic Revenue $3.4 billion in Q1 FY2026, a 2% increase year-over-year. Growth would have been approximately 5% without the calendar shift, primarily affecting Education. Growth driven by Workplace Experience, Refreshments, Healthcare, Sports and Entertainment, and Corrections.
International Organic Revenue $1.5 billion in Q1 FY2026, a 13% increase year-over-year. Growth driven by exceptional client retention and contributions from countries like the U.K., Spain, Germany, and Chile.
Operating Income $218 million in Q1 FY2026, slightly up year-over-year. Adjusted Operating Income (AOI) was $263 million, a 1% increase on a constant currency basis. AOI growth would have been approximately 11% without the calendar shift. Growth driven by higher revenue levels, technology leveraging, and cost management.
U.S. AOI 1% decline year-over-year in Q1 FY2026. Growth would have been approximately 9% without the calendar shift. Driven by revenue drop-through, technology efficiencies, and supply chain productivity.
International AOI 12% increase year-over-year on a constant currency basis in Q1 FY2026. Growth led by strong results in the U.K., Spain, and Chile, partially offset by mobilization costs and slight calendar shift impact.
Adjusted EPS $0.51 in Q1 FY2026, impacted by the calendar shift, which reduced growth by approximately 13%. Growth driven by higher revenue levels and cost efficiencies.
Cash Flow Cash outflow increased year-over-year in Q1 FY2026 due to greater working capital use from strong business growth. Capital expenditures were higher due to timing of commitments for new business wins and client renewals.
New Client Wins: Significant new client wins in healthcare, education, and corrections within the U.S., and in sports, mining, and energy internationally. Notable wins include Penn Medicine, RWJ Barnabas Health, and the University of Albany.
AI Integration: Proprietary AI platforms are being integrated for menu planning and operational efficiency, particularly in corrections and supply chain operations.
International Expansion: International revenue reached $1.5 billion, a 13% year-over-year increase. New business wins include Welsh Rugby Union and mining contracts in Latin America.
Global Supply Chain Growth: Double-digit growth in global supply chain operations, with over $20 billion in contracted spend. Expansion into adjacent hospitality areas like theme parks, hotels, and cruise lines.
Client Retention: Achieved unprecedented client retention levels in both U.S. and International segments.
Operational Efficiencies: AI-driven technology is enhancing supply chain productivity and providing real-time business insights.
Strategic Acquisitions: Focused on scaling through select strategic acquisitions to enhance global supply chain operations.
Financial Flexibility: Repriced $2.4 billion of term loans at lower interest rates, resulting in interest expense savings.
Calendar Shift Impact: The calendar shift caused a 3% to 4% unfavorable impact on growth in the first quarter, reducing revenue by approximately $125 million. This shift also affected profitability, reducing adjusted operating income (AOI) by an estimated $25 million.
Mobilization Costs: Mobilization costs in certain countries, particularly within Sports and Entertainment and Higher Education, partially offset profitability growth in the International segment.
Working Capital Use: Increased working capital use due to strong business growth led to higher cash outflows compared to the prior year.
Capital Expenditures: Higher capital expenditures were incurred due to the timing of commitments associated with sizable new business wins and certain client renewals.
Interest Expense: Interest expense was $81 million, and while steps were taken to optimize financial flexibility, interest costs remain a financial burden.
Revenue Growth: The company expects organic revenue growth of 7% to 9% for fiscal 2026, with strong performance anticipated in the second quarter due to onboarding new business and calendar shift benefits.
Adjusted Operating Income (AOI): AOI is projected to increase by 12% to 17% for fiscal 2026, driven by supply chain efficiencies, cost discipline, and higher revenue levels.
Adjusted EPS Growth: Adjusted EPS is expected to grow by 20% to 25% for fiscal 2026.
Leverage Ratio: The company aims to achieve a leverage ratio below 3x by the end of fiscal 2026.
Client Retention and New Business: The company anticipates maintaining high client retention levels and onboarding significant new business, including major contracts in healthcare, education, and corrections.
International Growth: International revenue is expected to continue its double-digit growth trajectory, with strong contributions from the U.K., Spain, Germany, and Chile.
Global Supply Chain and GPO: The company plans to expand its GPO network, targeting double-digit growth in contracted spend and leveraging AI-driven technology for operational efficiencies.
Share Repurchase Program: We continue to advance our capital allocation priorities by repurchasing another $30 million of Aramark shares as part of our share repurchase program.
The earnings call summary reveals strong financial performance, with positive growth in key areas such as revenue and operating income. The Q&A section highlights robust client retention, effective inflation management, and strategic investments in AI, enhancing productivity. Despite some unclear responses, the overall sentiment is positive, supported by strategic growth in Europe and new contracts. The company's optimistic guidance and focus on technology investments further bolster the positive outlook.
The earnings call summary indicates strong financial performance, strategic growth opportunities, and robust pipeline. Despite some delayed contract start-ups, the company maintains high retention rates and anticipates 7-9% growth in fiscal '26. Positive factors include a new partnership with Penn Medicine, strategic investments, and shareholder returns. While Q&A reveals some uncertainties, overall sentiment remains positive, suggesting a 2-8% stock price increase.
The earnings call summary reflects strong financial performance with high retention rates, significant new client wins, and strategic investments in technology and expansion. Despite some uncertainties in the Q&A section, management's confidence in achieving full-year guidance and the positive outlook for revenue growth and margin expansion support a positive sentiment. The proactive approach to shareholder returns through share repurchases further enhances the positive sentiment, outweighing minor concerns about margin variability and medical costs.
The earnings call highlights record revenue, a strong new business pipeline, and partnerships with major companies like Walmart. The management's guidance indicates robust growth expectations for revenue, AOI, and EPS, despite some uncertainties in specific verticals. The Q&A session reveals confidence in managing inflation and supply chain challenges. However, the lack of clarity on certain risks slightly tempers the overall sentiment. Given the strong financial performance and optimistic outlook, the stock price is likely to see a positive movement of 2% to 8%.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.